Enhanced Rodeferin broad spectrum
US11229603B1 · kind B1 · utility
0Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 1, 2021 |
| Grant date | Jan 25, 2022 |
| Priority date | — |
| Expiry date | Aug 1, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This process manufactures a finished medicine that can be used against broad spectrum, Anti-Viral, Anti-Bacterial, Anti-Fungal, and Anti-parasitic disease conditions that attack the human body but not limited to other medical conditions and or other types of treatments use for animals other than humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.